Federal Register / Vol. 85, No. 246 / Tuesday, December 22, 2020 / Notices 83583 

building permits, sediment and 

erosion control permits, grading 

permits, and stormwater management 

permits. 

Background 

In 1981, GSA completed an EIS that 

analyzed the impacts from the 

construction of new laboratory space at 

the MRC and the consolidation of four 

facilities in the Washington, DC, metro 

area and other sites in St. Louis, MO, 

and Cincinnati, OH. In 1990, Congress 

enacted the Food and Drug 

Revitalization Act that gave GSA the 

authority to grant contracts to 

consolidate FDA facilities. To 

accommodate future growth and further 

consolidate FDA operations, GSA is 

preparing an EIS to assess the impacts 

of development on the MRC and an 

increase in the employee population of 

up to approximately 1,800 employees, 

over a period of 20 years. 

The purpose of the proposed action is 

to provide a Master Plan for the MRC to 

guide future site development. The 

proposed action is needed to 

accommodate projected growth at the 

MRC and provide the necessary office 

and laboratory space for FDA to conduct 

complex and comprehensive research 

and reviews. 

Schedule for Decision-Making 

A Draft EIS is expected to be released 

for public review in June 2021. The GSA 

will hold a public hearing on the 

impacts of the proposed action in July 

2021, and will seek preliminary 

approval of the MRC Master Plan from 

the National Capital Planning 

Commission (NCPC) at NCPC’s 

September 2021 hearing. A Final EIS 

will be prepared that will take into 

consideration all comments received on 

the Draft EIS, and a Record of Decision 

is anticipated in spring 2022. Pending 

completion of NEPA compliance and 

review by NCPC, GSA anticipates 

adopting the MRC Master Plan in spring 

2022. 

Scoping Process 

In accordance with NEPA, a scoping 

process will be conducted to aid in 

determining the alternatives to be 

considered and the scope of issues to be 

addressed, as well as for identifying the 

significant issues related to the 

proposed MRC Master Plan. Scoping 

will be accomplished through a virtual 

public scoping meeting; direct mail 

correspondence to potentially interested 

persons, agencies, and organizations; 

and meetings with agencies having an 

interest in the Master Plan. It is 

important that Federal, regional, State, 

and local agencies, and interested 

individuals take this opportunity to 

identify environmental concerns that 

should be addressed during the 

preparation of the EIS. 

Public Scoping Meeting 

Due to the ongoing COVID–19 

pandemic and state/local requirements 

for social distancing, a pre-recorded 

presentation will be available at 

www.gsa.gov/ncrnepa in lieu of a 

traditional in-person public scoping 

meeting. A project phone line [410– 

777–9537] has also been set up to listen 

to the presentation and to leave 

comments on the proposed Master Plan. 

The pre-recorded presentation and 

phone line will be available from 

January 4, 2021, through February 11, 

2021. The GSA is publishing notices in 

the Washington Post and Prince 

George’s Post announcing the meeting. 

Written Comments 

Agencies and the public are 

encouraged to provide comments on 

identification of potential alternatives, 

information, and analyses relevant to 

the proposed action. Comments may be 

provided in writing via mail or email. 

Verbal comments may also be provided 

via the project phone line. Written 

comments regarding the environmental 

analysis for the proposed MRC Master 

Plan must be postmarked by February 

11, 2021, and sent to the following: Mr. 

Marshall Popkin, NEPA Compliance 

Specialist, Office of Planning and 

Design Quality, Public Buildings 

Service, U.S. General Services 

Administration, 1800 F Street NW, 

Room 4400, Washington, DC 20405. 

Email: marshall.popkin@gsa.gov 

using the subject line: FDA MRC Master 

Plan EIS Comment. 

Kristi Tunstall Williams, 

Deputy Director, Office of Planning and 

Design Quality, Public Buildings Service, 

National Capital Region, U.S. General 

Services Administration. 

[FR Doc. 2020–28212 Filed 12–21–20; 8:45 am] 

BILLING CODE 6820–Y1–P 

GENERAL SERVICES 

ADMINISTRATION 

[OMB Control No. 3090–0163; Docket No. 

2020–0001; Sequence No. 11] 

Submission for OMB Review; General 

Services Acquisition Regulation; 

Information Specific to a Contract or 

Contracting Action (Not Required by 

Regulation) 

AGENCY: Office of Acquisition Policy, 

General Services Administration (GSA). 

ACTION: Notice of request for public 

comments regarding an extension to an 

existing OMB information collection. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division will be 

submitting to the Office of Management 

and Budget (OMB) a request to review 

and approve an extension of a 

previously approved information 

collection requirement regarding 

information specific to a contract or 

contracting action that is not required 

by regulation. 

DATES: Submit comments on or before: 

January 21, 2021. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 30 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Clarence Harrison, Procurement 

Analyst, GSA Acquisition Policy 

Division, at telephone 202–227–7051 or 

email GSARPolicy@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

GSA has various mission 

responsibilities related to the 

acquisition and provision of supplies, 

transportation, information technology, 

telecommunications, real property 

management, and disposal of real and 

personal property. These mission 

responsibilities generate requirements 

that are realized through the solicitation 

and award of public contracts. 

Most GSA procurement-related 

information collections are required by 

the Federal Acquisition Regulation 

(FAR) or General Services 

Administration Acquisition Regulation 

(GSAR); each clause requiring such a 

collection must be individually 

approved by OMB. However, some 

solicitations require contractors to 

submit information specific to that 

contracting action, such as information 

needed to evaluate offers (e.g. specific 

instructions for technical and price 

proposals, references for past 

performance) or data used to administer 

resulting contracts (e.g. project 

management plans). 

This information collection is 

currently associated with GSA’s 

information collection requirements 

contained in solicitations issued in 

accordance with the Uniform Contract 

Format under FAR Part 14, Sealed 

Bidding (see GSAR 514.201–1); FAR 


jbell on DSKJLSW7X2PROD with NOTICES
83584 Federal Register / Vol. 85, No. 246 / Tuesday, December 22, 2020 / Notices 

Part 15, Contracting by Negotiation (see 

GSAR 552.215–73); and solicitations 

under FAR Part 12, Acquisition of 

Commercial Items (see GSAR 512.301). 

This includes information collection 

requirements found in GSA Federal 

Supply Schedule (FSS) solicitations. 

B. Annual Reporting Burden 

Respondents: 2,597,377. 

Responses per Respondent: 1. 

Total Responses: 2,597,377. 

Hours Per Response: .40. 

Total Burden Hours: 1,038,950. 

C. Public Comments 

A notice was published in the Federal 

Register at 85 FR 62731 on October 5, 

2020. Two comments were received. No 

changes were made to the information 

collection requirements or supporting 

statement as a result of the public 

comments, because they were not 

applicable to the policy. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the GSA Regulatory Secretariat Division, 

by calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 3090–0163, Information 

Specific to a Contract or Contracting 

Action (Not Required by Regulation), in 

all correspondence. 

Jeffrey Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2020–28187 Filed 12–21–20; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Solicitation for Nominations for 

Members of the U.S. Preventive 

Services Task Force (USPSTF) 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Solicits nominations for new 

members of the USPSTF. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) invites 

nominations of individuals qualified to 

serve as members of the U.S. Preventive 

Services Task Force (USPSTF). 

DATES: Nominations must be received 

electronically by March 15th of a given 

year to be considered for appointment to 

begin in January of the following year. 

ADDRESSES: Submit your responses 

electronically via: https://

uspstfnominations.ahrq.gov/register. 

FOR FURTHER INFORMATION CONTACT: 

Lydia Hill at coordinator@uspstf.net; 

301–427–1587. 

SUPPLEMENTARY INFORMATION: 

Arrangement for Public Inspection 

Nominations and applications are 

kept on file at the Center for Evidence 

and Practice Improvement, AHRQ, and 

are available for review during business 

hours. AHRQ does not reply to 

individual nominations, but considers 

all nominations in selecting members. 

Information regarded as private and 

personal, such as a nominee’s social 

security number, home and email 

addresses, home telephone and fax 

numbers, or names of family members 

will not be disclosed to the public in 

accord with the Freedom of Information 

Act. 5 U.S.C. 552(b)(6); 45 CFR 5.31(f). 

Nomination Submissions 

Nominations must be submitted 

electronically, and should include: 

1. The applicant’s current curriculum 

vitae and contact information, including 

mailing address, and email address; and 

2. A letter explaining how this 

individual meets the qualification 

requirements and how he or she would 

contribute to the USPSTF. The letter 

should also attest to the nominee’s 

willingness to serve as a member of the 

USPSTF. 

AHRQ will later ask people under 

serious consideration for USPSTF 

membership to provide detailed 

information that will permit evaluation 

of possible significant conflicts of 

interest. Such information will concern 

matters such as financial holdings, 

consultancies, non-financial scientific 

interests, and research grants or 

contracts. 

To obtain a diversity of perspectives, 

AHRQ particularly encourages 

nominations of women, members of 

underrepresented populations, and 

persons with disabilities. Interested 

individuals can nominate themselves. 

Organizations and individuals may 

nominate one or more people qualified 

for membership on the USPSTF at any 

time. Individuals nominated prior to 

March 15, 2020, who continue to have 

interest in serving on the USPSTF 

should be re-nominated. 

Qualification Requirements 

To qualify for the USPSTF and 

support its mission, an applicant or 

nominee should, at a minimum, 

demonstrate knowledge, expertise and 

national leadership in the following 

areas: 

1. The critical evaluation of research 

published in peer-reviewed literature 

and in the methods of evidence review; 

2. Clinical prevention, health 

promotion and primary health care; and 

3. Implementation of evidence-based 

recommendations in clinical practice 

including at the clinician-patient level, 

practice level, and health-system level. 

Additionally, the Task Force benefits 

from members with expertise in the 

following areas: 

D Public Health. 

D Health Equity and The Reduction 

Of Health Disparities. 

D Application of Science to Health 

Policy. 

D Dissemination and Implementation. 

D Behavioral Medicine/Clinical 

Health Psychology. 

D Communication of Scientific 

Findings to Multiple Audiences 

Including Health Care Professionals, 

Policy Makers and the General Public. 

Candidates with experience and skills 

in any of these areas should highlight 

them in their nomination materials. 

Applicants must have no substantial 

conflicts of interest, whether financial, 

professional, or intellectual, that would 

impair the scientific integrity of the 

work of the USPSTF and must be 

willing to complete regular conflict of 

interest disclosures. 

Applicants must have the ability to 

work collaboratively with a team of 

diverse professionals who support the 

mission of the USPSTF. Applicants 

must have adequate time to contribute 

substantively to the work products of 

the USPSTF. 

Nominee Selection 

Nominated individuals will be 

selected for the USPSTF on the basis of 

how well they meet the required 

qualifications and the current expertise 

needs of the USPSTF. It is anticipated 

that new members will be invited to 

serve on the USPSTF beginning in 

January, 2022. All nominated 

individuals will be considered; 

however, strongest consideration will be 

given to individuals with demonstrated 

training and expertise in the areas of 

Family Medicine, Internal Medicine, 

Pediatrics, Obstetrics and Gynecology, 

and Advanced Practice Nursing. AHRQ 

will retain and may consider for future 

vacancies nominations received this 

year and not selected during this cycle. 

Some USPSTF members without 

primary health care clinical experience 

may be selected based on their expertise 

in methodological issues such as metaanalysis, analytic modeling, or clinical 

epidemiology. For individuals with 

clinical expertise in primary health care, 

additional qualifications in 

methodology would enhance their 

candidacy. 


jbell on DSKJLSW7X2PROD with NOTICES